Zolpidem
- Generic Name
- Zolpidem
- Brand Names
- Ambien, Edluar, Intermezzo, Tovalt
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21N3O
- CAS Number
- 82626-48-0
- Unique Ingredient Identifier
- 7K383OQI23
- Background
Zolpidem, also known as Ambien, is a hypnotic drug that was initially approved by the FDA in 1992 . Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the duration of sleep, and decreases the number of awakenings during s...
- Indication
This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation .
- Associated Conditions
- Insomnia
- Associated Therapies
- -
A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia
- Conditions
- Interventions
- First Posted Date
- 2006-01-31
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 876
- Registration Number
- NCT00283946
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
- Conditions
- Interventions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- Hadine Joffe, MD
- Target Recruit Count
- 86
- Registration Number
- NCT00227942
- Locations
- 🇺🇸
MGH Center for Perinatal and Women's Mental Health, Boston, Massachusetts, United States
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-03-30
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 69
- Registration Number
- NCT00177216
- Locations
- 🇺🇸
Western Psychiatric Institute and Clinic/ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 20
- Registration Number
- NCT00156533
- Locations
- 🇺🇸
University of Rochester Sleep Research Laboratory, Rochester, New York, United States
Behavioral and Pharmacological Treatment for Insomnia
- Conditions
- First Posted Date
- 2002-07-26
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Laval University
- Target Recruit Count
- 160
- Registration Number
- NCT00042146
- Locations
- 🇨🇦
Laval University, Quebec City, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.